HSP90B1 and ulcerative colitis: For inflammatory diseases, compound 54, reported by Jiang et al. 54to selectively inhibit HSP90B1, has also been found to be effective in a mouse model of ulcerative colitis. HSP90B1 expression was also upregulated in the present microarray analysis; thus, HSP90B1 may be a therapeutic target in AD.